Molecular Imaging Markers to Track Huntington’s Disease Pathology
about
Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.Metformin reverses early cortical network dysfunction and behavior changes in Huntington's diseaseDifferential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease
P2860
Molecular Imaging Markers to Track Huntington’s Disease Pathology
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Molecular Imaging Markers to Track Huntington’s Disease Pathology
@ast
Molecular Imaging Markers to Track Huntington’s Disease Pathology
@en
type
label
Molecular Imaging Markers to Track Huntington’s Disease Pathology
@ast
Molecular Imaging Markers to Track Huntington’s Disease Pathology
@en
prefLabel
Molecular Imaging Markers to Track Huntington’s Disease Pathology
@ast
Molecular Imaging Markers to Track Huntington’s Disease Pathology
@en
P2860
P356
P1476
Molecular Imaging Markers to Track Huntington's Disease Pathology
@en
P2093
Flavia Niccolini
Marios Politis
P2860
P356
10.3389/FNEUR.2017.00011
P577
2017-01-30T00:00:00Z